Voyager Therapeutics, Inc.
USD3.58
-0.01 (-0.28%)
CEO
Alfred W. Sandrock Jr.
IPO Date
2015-11-11
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.58
Prev. Close
$3.59
Day Low
$3.52
Day High
$3.72
52W Low
$2.88
52W High
$5.55
Market Cap
$0.22B
Volume
0.65M
| -5.0 |
| 31 Dec 2023 | FY | 63.1% | 52.9% | 56.0% | 37.7% | 0.09 | 4.96 | 2.7 |
| 31 Dec 2022 | FY | -36.3% | -113.4% | -78.6% | -29.1% | 0.39 | 1.72 | -5.0 |
| 31 Dec 2021 | FY | -97.2% | -190.3% | -74.9% | -36.7% | 0.46 | 2.68 | -1.4 |
| 31 Dec 2020 | FY | 36.4% | 21.5% | 23.8% | 14.0% | 0.31 | 7.39 | 7.2 |
| 31 Dec 2019 | FY | -14.7% | -41.8% | -43.8% | -12.3% | 0.34 | 4.01 | -11.5 |
| 31 Dec 2018 | FY | -751.9% | -1158.8% | -190.1% | -49.9% | 0.00 | 5.13 | -3.4 |
| 31 Dec 2017 | FY | -514.3% | -697.6% | -52.7% | -38.3% | 0.00 | 10.81 | -6.3 |
| 31 Dec 2016 | FY | -197.1% | -282.7% | -29.6% | -21.2% | 0.00 | 12.95 | -8.0 |
| -2.1 |
| 30 Sept 2025 | Q3 | 100.0% | -208.7% | -12.7% | -9.7% | 0.17 | 6.19 | -2.5 |
| 30 Jun 2025 | Q2 | 100.0% | -642.0% | -13.7% | -10.4% | 0.16 | 5.43 | -1.4 |
| 31 Mar 2025 | Q1 | 100.0% | -479.2% | -11.4% | -8.8% | 0.15 | 6.10 | -1.6 |
| 31 Dec 2024 | Q4 | 100.0% | -549.3% | -11.5% | -8.8% | 0.15 | 5.56 | -2.4 |
| 30 Sept 2024 | Q3 | 100.0% | -36.7% | -2.7% | -2.1% | 0.14 | 8.45 | -9.4 |
| 30 Jun 2024 | Q2 | -8.0% | -34.3% | -3.0% | -2.3% | 0.14 | 9.51 | -11.2 |
| 31 Mar 2024 | Q1 | 93.9% | -58.1% | -3.3% | -2.4% | 0.14 | 5.64 | -13.3 |
| 31 Dec 2023 | Q4 | 98.5% | 62.6% | 23.9% | 16.1% | 0.09 | 4.96 | 1.6 |